Menu

• Ask a Health Expert about SUBCUTANEOUS NODULE
• Post Your Side Effect related to SUBCUTANEOUS NODULE
• SUBCUTANEOUS NODULE and FDA Warnings
• SUBCUTANEOUS NODULE in Patients Wiki
• Report SUBCUTANEOUS NODULE in Drug Side Effect Survey

SUBCUTANEOUS NODULE side effect

What is SUBCUTANEOUS NODULE ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Heparin Side Effects Report #5669253-6
Physician from UNITED STATES reported HEPARIN problem on Mar 13, 2008. Female patient, 85 years of age, weighting 209.0 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: subcutaneous nodule, . HEPARIN dosage: 90 MGM BID SQ. Patient recovered.

Vytorin Side Effects Report #5637677-9
VYTORIN problem was reported by a Health Professional from FRANCE on Feb 15, 2008. Female patient, 31 years of age, was diagnosed with type iia hyperlipidaemia and was treated with VYTORIN. After drug was administered, patient experienced the following problems/side effects: subcutaneous nodule, tendon disorder, . VYTORIN dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM. Patient was hospitalized and became disabled. Patient recovered.

Vytorin Side Effects Report #5639544-3
Health Professional from FRANCE reported VYTORIN problem on Feb 15, 2008. Female patient, 31 years of age, was diagnosed with type iia hyperlipidaemia and was treated with VYTORIN. After drug was administered, patient experienced the following problems/side effects: subcutaneous nodule, tendon disorder, . VYTORIN dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM. Patient was hospitalized and became disabled. Patient recovered.

Zoladex Side Effects Report #5452726-9
ZOLADEX problem was reported by a Health Professional from JAPAN on Sept 05, 2007. Male patient, 81 years of age, was diagnosed with prostate cancer and was treated with ZOLADEX. After drug was administered, patient experienced the following problems/side effects: subcutaneous nodule, . ZOLADEX dosage: unknown. During the same period patient was treated with LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE. Patient recovered.


Fertinorm Side Effects Report #5387585-6
Health Professional from JAPAN reported FERTINORM P problem on June 27, 2007. Female patient, 44 years of age, weighting 99.21 lb, was treated with FERTINORM P. After drug was administered, patient experienced the following problems/side effects: subcutaneous nodule, . FERTINORM P dosage: unknown. Patient was hospitalized. Patient recovered.

Fertinorm Side Effects Report #5387585-6
FERTINORM P problem was reported by a Health Professional from JAPAN on June 27, 2007. Female patient, 44 years of age, weighting 99.21 lb, was treated with FERTINORM P. After drug was administered, patient experienced the following problems/side effects: subcutaneous nodule, . FERTINORM P dosage: unknown. Patient was hospitalized. Patient recovered.

Enbrel Side Effects Report #5352950-X
Physician from JAPAN reported ENBREL problem on May 30, 2007. Female patient, 67 years of age, was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: subcutaneous nodule, . ENBREL dosage: unknown. During the same period patient was treated with PREDONINE, MARZULENE, ISCOTIN, EVISTA, RHEUMATREX, PARIET. Patient was hospitalized. Patient recovered.

Zoladex Side Effects Report #5375150-6
ZOLADEX problem was reported by a Health Professional from UNITED STATES on Apr 04, 2007. Female patient, 56 years of age, was diagnosed with breast cancer female and was treated with ZOLADEX. After drug was administered, patient experienced the following problems/side effects: subcutaneous nodule, . ZOLADEX dosage: unknown. Patient recovered.

Lamotrigine Side Effects Report #5595779-X
Consumer or non-health professional from UNITED STATES reported LAMOTRIGINE problem on Jan 07, 2008. Male patient, 68 years of age, was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: lymphoid tissue hyperplasia, subcutaneous nodule, . LAMOTRIGINE dosage: unknown. Patient recovered.


Lamotrigine Side Effects Report #5603189-1
LAMOTRIGINE problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 07, 2008. Male patient, 68 years of age, was diagnosed with convulsion and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: lymphoid tissue hyperplasia, subcutaneous nodule, t-cell lymphoma, . LAMOTRIGINE dosage: unknown. Patient recovered.

Byetta Side Effects Report #5647989-0
Consumer or non-health professional from UNITED STATES reported BYETTA problem on Nov 27, 2007. Female patient, 60 years of age, weighting 149.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: muscle spasms, subcutaneous nodule, weight decreased, . BYETTA dosage: unknown. During the same period patient was treated with GLYBURIDE, VYTORIN, METFORMIN. Patient recovered.

Xolair Side Effects Report #5391747-1
XOLAIR problem was reported by a Consumer or non-health professional from SWITZERLAND on July 16, 2007. Female patient was treated with XOLAIR. After drug was administered, patient experienced the following problems/side effects: pain, subcutaneous nodule, . XOLAIR dosage: unknown. Patient recovered.

Xolair Side Effects Report #5391747-1
Consumer or non-health professional from SWITZERLAND reported XOLAIR problem on July 16, 2007. Female patient was treated with XOLAIR. After drug was administered, patient experienced the following problems/side effects: pain, subcutaneous nodule, . XOLAIR dosage: unknown. Patient recovered.

Byetta Side Effects Report #5774349-4
BYETTA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 27, 2008. Female patient, 56 years of age, weighting 269.8 lb, was diagnosed with type 2 diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered, subcutaneous nodule, . BYETTA dosage: unknown. Patient recovered.


Rituxan Side Effects Report #5317798-0
Consumer or non-health professional from UNITED STATES reported RITUXAN problem on Apr 25, 2007. Female patient was diagnosed with polymyositis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: mycobacterial infection, subcutaneous nodule, . RITUXAN dosage: 750 MG, SINGLE. During the same period patient was treated with METHOTREXATE, PREDNISONE, ANTIHISTAMINE NOS, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.

Forteo Side Effects Report #5308257-X
FORTEO problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2007. Female patient, 65 years of age, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: calcinosis, subcutaneous nodule, . FORTEO dosage: unknown. Patient was hospitalized. Patient recovered.

Arimidex Side Effects Report #5281562-1
Physician from UNITED STATES reported ARIMIDEX problem on Mar 26, 2007. Female patient, 57 years of age, weighting 200.4 lb, was diagnosed with breast cancer female and was treated with ARIMIDEX. After drug was administered, patient experienced the following problems/side effects: panniculitis, subcutaneous nodule, . ARIMIDEX dosage: unknown. Patient recovered.

Navelbine Side Effects Report #5660295-3
NAVELBINE problem was reported by a Health Professional from FRANCE on Feb 20, 2008. Male patient was diagnosed with hodgkin's disease and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: pyrexia, rash, subcutaneous nodule, . NAVELBINE dosage: 10 MG/ML QD IV. During the same period patient was treated with METHYL, ETOPOPHOS PRESERVATIVE FREE, UROMITEXAN, HOLOXAN, ZOPHREN. Patient was hospitalized. Patient recovered.